about
Characterization and Functions of Protease-Activated Receptor 2 in Obesity, Diabetes, and Metabolic Syndrome: A Systematic ReviewProteinases, their receptors and inflammatory signalling: the Oxford South Parks Road connectionVisceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteasesG protein-coupled receptors in cardiac biology: old and new receptorsNoncanonical PAR3 activation by factor Xa identifies a novel pathway for Tie2 activation and stabilization of vascular integrity.Macrophage Migration Inhibitory Factor Mediates PAR-Induced Bladder Pain.Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1.Protein Kinase D and Gβγ Subunits Mediate Agonist-evoked Translocation of Protease-activated Receptor-2 from the Golgi Apparatus to the Plasma Membrane.PH motifs in PAR1&2 endow breast cancer growth.Protease-activated receptors in hemostasis.Mechanisms of the adenosine A2A receptor-induced sensitization of esophageal C fibersTeleocidin A2 inhibits human proteinase-activated receptor 2 signaling in tumor cells.Protease receptor antagonism to target blood platelet therapies.Protease-activated receptors and their biological role - focused on skin inflammation.Insights into cellular signalling by G protein coupled receptor transactivation of cell surface protein kinase receptors.Coagulation and non-coagulation effects of thrombin.Gaq proteins: molecular pharmacology and therapeutic potential.The Role of Proteinase-Activated Receptors 1 and 2 in the Regulation of Periodontal Tissue Metabolism and Disease.Homeostatic effects of coagulation protease-dependent signaling and protease activated receptors.PAR2-dependent activation of GSK3β regulates the survival of colon stem/progenitor cells.Comparison of the activation peptide regions of protease-activated receptors (PAR) in members of the Family Felidae.PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo.Allergen-dependent oxidant formation requires purinoceptor activation of ADAM 10 and prothrombin.Protease-Activated Receptor 2 Promotes Pro-Atherogenic Effects through Transactivation of the VEGF Receptor 2 in Human Vascular Smooth Muscle Cells.Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease-activated receptor-2.Integrating the GPCR transactivation-dependent and biased signalling paradigms in the context of PAR1 signalling.Inhibition of Protease-Activated Receptor 1 Does not Affect Dendritic Homeostasis of Cultured Mouse Dentate Granule Cells.PAR1-stimulated platelet releasate promotes angiogenic activities of endothelial progenitor cells more potently than PAR4-stimulated platelet releasate.Plasmin reduces fibronectin deposition by mesangial cells in a protease-activated receptor-1 independent manner.Tissue Factor-Expressing Tumor-Derived Extracellular Vesicles Activate Quiescent Endothelial Cells via Protease-Activated Receptor-1.Protease activated-receptor 2 is necessary for neutrophil chemorepulsion induced by trypsin, tryptase, or dipeptidyl peptidase IV.MicroRNA-205 Mediates Proteinase-Activated Receptor 2 (PAR2) -Promoted Cancer Cell Migration.Protease signaling regulates apical cell extrusion, cell contacts, and proliferation in epithelia.Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy.The TRPM7 kinase limits receptor-induced calcium release by regulating heterotrimeric G-proteins.The Platelet Lifeline to Cancer: Challenges and Opportunities.Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis.Skin neurogenic inflammation.Protease activated receptor 4: a backup receptor or a dark horse as a target in antiplatelet therapy?
P2860
Q26752383-533FA159-AE96-47AA-9549-61AE4BE03BFEQ28647166-763BEC00-94CD-4015-973D-390B38DB81D6Q28818844-9C3F6C90-DD86-4AD2-9C4D-DD52B6111D6BQ33639685-1D276534-9BD7-4E2E-BA44-AB5866671A1CQ34580126-F49C13F6-D60F-462A-9AC4-644EC3F76CC4Q35644788-FE5E8671-F294-48D0-A545-D5F2C3E84AD8Q35968763-CB93E0BF-8C18-4483-A6B6-86341091E6F8Q35974569-E6183C9D-C370-4EBD-94BD-CF7593EDE32CQ36357012-1D4392E0-BAA9-4622-B42B-2B1CB3F0D23EQ37097085-118361D0-14A4-4AEF-B4C1-307BC81B3AFBQ37148733-699DA691-4E94-4E3A-8E47-B44913B5C803Q37591794-DF91AA8E-0E3F-457A-8D45-4DB97BB64659Q38616508-E57D443C-55A9-4F2A-8A0E-840B5FBF790DQ38680840-4E7153FE-E6B8-423D-A261-549D6226B9BAQ38760567-AD6BB969-05A1-4E7E-BC0C-4664CDB365E8Q38924721-1E163894-9E38-4409-AF12-8B7558A91772Q38999227-BE19225D-B651-4B19-9512-595E180CA27AQ39306127-3EB511E2-9884-4FAB-AF33-5DB67B7997BCQ39410950-EE3FFC12-F52B-4A4F-B22A-9623DFE28709Q39676378-EE2C4C47-6238-453C-B224-DCA6B2EA1A87Q39690063-4884C729-2999-47B7-8C11-4B460EBD83BCQ40263863-1CF8EBC9-1356-4EAC-8F55-7FEB7BC2895EQ40362480-23BA1297-1D9E-48E6-BF94-80828819B677Q40630385-22896F68-7E5F-4124-BBAE-F544C7AAF133Q41341638-A7E8D96C-BEA9-4182-B6EC-31710B42A6B8Q41635414-47C9D294-C74A-405C-8844-4625633B2430Q42082620-2CDD98DE-97AB-4F4E-BC98-C74295A782EAQ42470113-4FDC587C-F4D2-45BB-AAD4-BC2D68F03056Q47142090-9984D022-7440-404B-B527-5DCCAD6D0296Q47325159-B466C93F-1560-42BA-8F63-4782BD474FB8Q47551897-5EC1B532-5E33-45CC-BE79-2123D96D2599Q47678549-41AB295C-B6BF-40F8-B86E-7EAB66F8EF40Q48307273-7D90FBB8-5DBD-44A3-9F72-5EEEF534706DQ50002204-78397A49-F220-424D-81B6-AB679FEE2511Q52689073-255910C6-3334-4526-9647-730AF611982DQ52719266-A5A729EA-571A-4F1E-828C-23756C309450Q52721277-47BAF25E-A563-4F2C-BB30-3A2A1AF9B690Q54224167-2C83F51D-254C-402A-ABD0-0C11FF2AD006Q55102493-F6383ED3-5EF1-4000-83F4-472BA56FC86D
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biased signaling of protease-activated receptors.
@en
type
label
Biased signaling of protease-activated receptors.
@en
prefLabel
Biased signaling of protease-activated receptors.
@en
P2093
P2860
P356
P1476
Biased signaling of protease-activated receptors.
@en
P2093
Matthew Metcalf
Nigel W Bunnett
Peishen Zhao
P2860
P356
10.3389/FENDO.2014.00067
P577
2014-05-13T00:00:00Z